MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies-Reference-Cited by-同舟云学术

MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies

Published:2014-03 Issue:1 Volume:13 Page:37-45.e4
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Cappuzzo Federico,Sacconi Andrea,Landi Lorenza,Ludovini Vienna,Biagioni Francesca,D'Incecco Armida,Capodanno Alessandra,Salvini Jessica,Corgna Enrichetta,Cupini Samanta,Barbara Cecilia,Fontanini Gabriella,Crinò Lucio,Blandino Giovanni

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference40 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2012

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets;Clinical and Translational Medicine;2023-09

2. The role of miRNA in colorectal cancer diagnosis: A pilot study;Oncology Letters;2023-05-04

3. Bioinformatics and Expression Analyses of miR-639, miR-641, miR-1915-3p and miR-3613-3p in Colorectal Cancer Pathogenesis;2023-04-17

4. Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI;Cancers;2022-10-03

5. Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy;Cell Communication and Signaling;2022-09-21